diflunisal has been researched along with thyroxine in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (16.67) | 18.7374 |
| 1990's | 2 (16.67) | 18.2507 |
| 2000's | 3 (25.00) | 29.6817 |
| 2010's | 4 (33.33) | 24.3611 |
| 2020's | 1 (8.33) | 2.80 |
| Authors | Studies |
|---|---|
| Strassburg, CP; Tukey, RH | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Arsequell, G; Blasi, D; Bosch, L; Centeno, NB; Cotrina, EY; Pinto, M; Planas, A; Quintana, J; Valencia, G; Vilà, M | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Barlow, JW; Curtis, AJ; Lim, CF; Stockigt, JR; Topliss, DJ | 1 |
| Barlow, JW; Craik, DJ; Hall, JG; Lim, CF; Munro, SL; Stockigt, JR; Topliss, DJ | 1 |
| Huisman, JW | 1 |
| Barlow, JW; Curtis, AJ; Lim, CF; Stockigt, JR; Topliss, DJ; Wynne, KN | 1 |
| Green, NS; Kelly, JW; Palaninathan, SK; Sacchettini, JC | 1 |
| Almeida, MR; Alves, I; Arsequell, G; Cardoso, I; Macedo, B; Planas, A; Saraiva, MJ; Valencia, G | 1 |
| Andersson, PL; Begum, A; Brännström, K; Iakovleva, I; Nilsson, L; Olofsson, A; Sauer-Eriksson, AE; Wijsekera, A; Zhang, J | 1 |
| Arsequell, G; Cardoso, I; Cotrina, EY; Gales, L; Leite, JP; Llop, J; Oliveira, Â; Quintana, J | 1 |
2 review(s) available for diflunisal and thyroxine
| Article | Year |
|---|---|
Human UDP-glucuronosyltransferases: metabolism, expression, and disease.
Topics: Autoimmunity; Chromosome Mapping; Glucuronides; Glucuronosyltransferase; Humans; Hyperbilirubinemia; Neoplasms; Steroids; Terminology as Topic | 2000 |
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
10 other study(ies) available for diflunisal and thyroxine
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Modulation of the fibrillogenesis inhibition properties of two transthyretin ligands by halogenation.
Topics: Diflunisal; Flufenamic Acid; Halogenation; Humans; Kinetics; Ligands; Models, Molecular; Prealbumin; Protein Multimerization; Protein Structure, Secondary; Structure-Activity Relationship | 2013 |
Interactions between oleic acid and drug competitors influence specific binding of thyroxine in serum.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Binding, Competitive; Diflunisal; Furosemide; Humans; Kinetics; Meclofenamic Acid; Mefenamic Acid; Oleic Acid; Oleic Acids; Phenylacetates; Thyroxine; Thyroxine-Binding Proteins | 1991 |
Drug competition for thyroxine binding to transthyretin (prealbumin): comparison with effects on thyroxine-binding globulin.
Topics: Binding Sites; Binding, Competitive; Biological Transport; Diflunisal; Flufenamic Acid; Hydrogen-Ion Concentration; Mefenamic Acid; Prealbumin; Salicylates; Structure-Activity Relationship; Thyroxine; Thyroxine-Binding Proteins; Triiodothyronine | 1989 |
Interference by diflunisal with the FETI method for serum thyroxine.
Topics: Diflunisal; False Negative Reactions; Fluorescent Antibody Technique; Humans; Radioimmunoassay; Salicylates; Thyroxine | 1986 |
A naturally occurring furan fatty acid enhances drug inhibition of thyroxine binding in serum.
Topics: Analysis of Variance; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Binding, Competitive; Diflunisal; Dose-Response Relationship, Drug; Drug Interactions; Fatty Acids, Nonesterified; Furans; Furosemide; Humans; Oleic Acid; Oleic Acids; Phenylacetates; Prealbumin; Propionates; Thyroxine; Thyroxine-Binding Proteins; Triiodothyronine | 1993 |
Synthesis and characterization of potent bivalent amyloidosis inhibitors that bind prior to transthyretin tetramerization.
Topics: Amyloid; Amyloidosis; Biphenyl Compounds; Crystallography, X-Ray; Dicarboxylic Acids; Diflunisal; Drug Design; Humans; Kinetics; Models, Molecular; Prealbumin; Protein Binding; Protein Folding; Thyroxine | 2003 |
Selective binding to transthyretin and tetramer stabilization in serum from patients with familial amyloidotic polyneuropathy by an iodinated diflunisal derivative.
Topics: Amyloid Neuropathies; Diclofenac; Diflunisal; Flufenamic Acid; Humans; Iodine; Iodobenzoates; Molecular Structure; Prealbumin; Protein Binding; Thyroxine | 2004 |
Tetrabromobisphenol A Is an Efficient Stabilizer of the Transthyretin Tetramer.
Topics: Amyloid; Amyloidosis; Benzoxazoles; Binding Sites; Cell Line, Tumor; Crystallography, X-Ray; Diflunisal; Drug Design; Excipients; Half-Life; Humans; Ligands; Polybrominated Biphenyls; Prealbumin; Protein Binding; Thyroxine | 2016 |
Repurposing Benzbromarone for Familial Amyloid Polyneuropathy: A New Transthyretin Tetramer Stabilizer.
Topics: Amyloid; Benzbromarone; Benzoxazoles; Binding Sites; Binding, Competitive; Crystallography, X-Ray; Diflunisal; Drug Repositioning; Gene Expression; Humans; Hydrogen Bonding; Kinetics; Molecular Docking Simulation; Neuroprotective Agents; Prealbumin; Protein Binding; Protein Conformation, alpha-Helical; Protein Conformation, beta-Strand; Protein Interaction Domains and Motifs; Protein Multimerization; Protein Stability; Recombinant Proteins; Thermodynamics; Thyroxine; Tolcapone | 2020 |